# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-006050
Filing Date
2018-04-02
Accepted
2018-04-02 16:02:44
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | dffn20171231_10k.htm | 10-K | 1698250
2 | EXHIBIT 10.5 | ex_108103.htm | EX-10.5 | 63257
3 | EXHIBIT 21.1 | ex_108104.htm | EX-21.1 | 6749
4 | EXHIBIT 23.1 | ex_108150.htm | EX-23.1 | 3461
5 | EXHIBIT 31.1 | ex_108105.htm | EX-31.1 | 14990
6 | EXHIBIT 31.2 | ex_108106.htm | EX-31.2 | 15017
7 | EXHIBIT 32.1 | ex_108107.htm | EX-32.1 | 6681
14 |  | kpmgsig.jpg | GRAPHIC | 2562
15 |  | a6.jpg | GRAPHIC | 18202
16 |  | a5.jpg | GRAPHIC | 82331
17 |  | a4.jpg | GRAPHIC | 25029
18 |  | a3.jpg | GRAPHIC | 30903
19 |  | a2.jpg | GRAPHIC | 40638
20 |  | a1.jpg | GRAPHIC | 62891
| Complete submission text file | 0001437749-18-006050.txt |  | 7619866

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL INSTANCE DOCUMENT | dffn-20171231.xml | EX-101.INS | 1161203
9 | XBRL TAXONOMY EXTENSION SCHEMA | dffn-20171231.xsd | EX-101.SCH | 74635
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dffn-20171231_cal.xml | EX-101.CAL | 49982
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dffn-20171231_def.xml | EX-101.DEF | 618167
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dffn-20171231_lab.xml | EX-101.LAB | 458429
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dffn-20171231_pre.xml | EX-101.PRE | 629841

Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 18728866
SIC: 2834 Pharmaceutical Preparations